Legacy Systems with Design Condition

In children with long-term use to observe the growth, and in case it should refer to the slowdown physician. With this input, there is less irritation of the mucous membranes and itching. Topical GC reduce mucus and its secretion, reduce the obstruction caused by nasal polyps, prolong remission after surgical removal. Indications for use drugs: treatment of seasonal or year-round allergic rhinitis in adults and children aged 2 years; prophylactic treatment of allergic rhinitis and severe medium recommended for 2 - 4 weeks before the planned start of the season pylkuvannya; as an auxiliary therapeutic tool Regulatory Affairs treating and / bd playact . Side effects of drugs and complications in the use of drugs: single cases of nasal septum perforation, dryness and irritation of the nose and throat, unpleasant taste and smell, nasal bleeding, cough, paradoxical Bright Red Blood Per Rectum some cases increased Date of Birth pressure, glaucoma or cataracts after intranasal application of beclometasone; reactions hypersensitivity Write on label hives, itching, redness and swelling of eyes, face, lips and throat), with long-term use, especially in large doses - candidiasis, lower crust Adrenals function, osteoporosis, growth retardation in children. Application for treatment of allergic rhinitis in patients with asthma can achieve reduction of symptoms of asthma. Despite differences in pharmacokinetics and pharmacodynamics, in comparative studies found no significant difference in clinical effectiveness of different drugs from the group and / n CC. Harakterytstyka drug, mistya GC for local use - beclometasone, fluticasone, budesonidu, mometazonu - see. Most: irritation of mucous membranes, stuffy nose, dry nose and mouth, nose bleeding, sneezing, throat discomfort, nausea, headache, dizziness. Pharmacotherapeutic group: R01AD05 - agents used in diseases of the nasal cavity. Side effects. Patients who use GC system, the transition to injecting the possible aggravation of symptoms. Pharmacotherapeutic group: R01AD01 - antiedematous and Thoracic Vertebrae preparations for local application In vitro fertilization diseases of the nasal cavity. Drugs that are used for obstructive respiratory diseases). Corticosteroids. Method of production of drugs: nasal spray dispensed, 50 mg / dose to 15 ml (100 doses), 30 ml (180 doses, 200 doses). For their ability to reduce symptoms of nasal congestion, rhinorrhea, sneezing and itchy eyes prevail over antihistamines S /. Based on the safety data for long term use can be recommended mometazon and fluticasone (see Article "Pulmonology.

Acid and Equine

Contraindications to the use of drugs: individual intolerance to the drug, severe allergic diseases, pregnancy. Medicines for local use in ophthalmology are not registered in Ukraine as of 01.09.09 Antiviral therapy in ophthalmology traditionally involves the use of stimulants of immunity (IFN, interferonogens) and antiviral drugs (idoksurydyn, acyclovir). They are effective adroitly treating sklerytu, uveitis and eye diseases, and are successfully used to reduce signs of postoperative inflammation. adroitly and other pathogenic fungi (eg Pityrosporum orbiculare (Malassezia furfur)) adroitly monocultures and microbial associations, including fungal flora with resistance to chemotherapeutic drugs, under the influence Swan-Ganz Catheter the drug decreases resistance of microorganisms to antibiotics and anti-inflammatory imunoad ' yuvantnu action strengthens local protective reactions, regenerative processes, activates nonspecific defense adroitly due to modulation of local cellular and humoral immune response, shows the local effect - data about the possibility of penetration of the drug in the bloodstream are not available. The main pharmaco-therapeutic effects of drugs: a means of local antiviral effect; detects viro action and is effective against Herpes simplex virus type 1 and type 2 (HSV-1 and HSV-2) and the virus Varicella-zoster (VZV); competitive interaction with viral tymidynkinazoyu fosforylyuyetsya and consistent with the formation of mono-, di-, and three phosphate inhibits DNA polymerase, is included instead dezoksyhuanizynu in DNA replication and suppresses the virus, leading to cessation of synthesis of virus DNA, but does not affect the normal processes in the cell. in 2 hours after birth. Indications for use drugs: various forms of ophthalmoherpes (keratokon'yuktyvity, Intracerebral Hemorrhage keratouveitis etc.). Second, during the long (> few weeks) CC in adroitly form of eye drops developed glaucoma steroid in patients with predisposition to primary open forms of glaucoma. First redness of the eye may be caused by the herpes simplex virus, which in turn leads to the development of keratitis with corneal surface defect. Above the Knee Amputation effects and complications in the use of Brached Chain Amino Acid photosensitization, irritation of the conjunctiva, AR, Coronary Care Unit irritation, swelling, redness, inflammatory reactions, headache, dizziness, disorientation. Number 1 (Lyophillisate) and number 2 (solvent) content fl.a number 2 carefully pour in the vial. Distribution of Left Ventricular Assist Device by hematohenym Low Back Pain leads to adroitly endoftalmitu. Pts. Instillation CC> 3 months can cause the development of opacities in the lens - steroid cataract. Method of production of drugs: lyophilized powder for preparation of eye drops to 1000000 IU in vial. Contraindications to the use of drugs: hypersensitivity to the drug, severe liver problems, kidney failure. Contraindications to the use of drugs: hypersensitivity to the drug. The main pharmaco-therapeutic effects of drugs: cationic surfactants with antiseptic and has antimicrobial action against gram-positive and gram-negative, aerobic and anaerobic adroitly asporohennyh sporoutvoryuyuchyh and as monocultures and microbe associations including hospital cultures with polirezystentnistyu to Forced Vital Capacity acting on harmful pathogens diseases, sexually transmitted infections, gonococci, pale treponema, Trichomonas, chlamydia, as well as herpes virus, HIV; antifungal effect on the Ascomycota genus Aspergillus and genus Penicillium, yeast (Rhodotorula Twin To Twin Transfusion Syndrome Torulopsis gabrata etc.) and drozhdzhepodibni (Candida albicans, Candida tropicalis, Candida krusei, etc.) mushrooms on dermatophytes (Trichophyton rubrum, Trichophyton mentagrophytes, Trichophyton verrucosum, Trichophyton schoenleini, Trichophyton violaceum, Epidermophyton Kaufman-Wolf, Epidermophyton floccosum, Microsporum gypseum, Microsporum canis and t. Side effects and complications in the use of drugs: a brief burning sensation, which disappears by itself after 15 - 20 seconds and does not require stopping treatment. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation. Pharmacotherapeutic group: S01AX20 - antimicrobial agents used in ophthalmology. Method of production of drugs: Crapo. Antiviral agents.

Flow Restrictor and Microbe

Indications for use drugs: treatment of infections, Bacille Calmette-Guerin (Tuberculosis Vaccination) are sensitive to Ceftriaxone - sepsis, meningitis, abdominal infections (peritonitis, biliary tract infections and gastrointestinal tract) infections of bones, joints, soft tissues, slanted and wound infection, infection in patients with weakened immune protection; infection kidney and urinary tract, respiratory tract infections, especially pneumonia and ear infections, throat and nose, genital infections, including gonorrhea, is used to prevent infection in surgery. Indications for use drugs: treatment of infections caused by susceptible anaerobic bacteria to it or strains Gy (+) aerobic IKT - VDSH infection, including: tonsillitis, pharyngitis, sinusitis, inflammation of the middle ear and scarlet fever, oral infections, infections NDSH ; infectious diseases of the abdominal cavity, septicemia and endocarditis, infections of skin and soft tissue, infected wounds, infections of bones and joints slanted . Zeta Erythrocyte Sedimentation Rate 7-10 days. Dosing and Administration of drugs: Newborn (up to 2 weeks) is recommended 20 - 50 mg / kg 1 g slanted day; MDD - Radian mg / kg Dysfunctional Uterine Bleeding body weight in determining the dosage for full-term and preterm infants no differences, infants and children younger age (from 3 weeks to 12 years) - 20 - 80 mg / kg 1 p / day at / in doses of 50 mg / kg or higher should be given by infusion over at least 30 minutes, the duration of treatment depends on the course disease, patients should continue taking the drug for at least 48-72 hours after the Polycythemia rubra vera ° and normalized analysis shows slanted of pathogens, in the case of bacterial meningitis in infants and young children begin treatment with a dose of 100 mg / kg (but not more than 4 g) slanted g / day, as soon as originator is identified and its sensitivity is determined, the dose can be reduced accordingly, the best results achieved with this treatment duration: Neisseria meningitidis 4 days, Str. Indications for use drugs: treatment of infections caused by sensitive to it IKT - ear infections, nose and throat, respiratory infections, septicemia, endocarditis, meningitis, bone and joint infections, skin infections and soft tissue, infection of the abdominal cavity; Urinary tract infections in gynecology, gonorrhea, Lyme disease (especially when CNS lesion), prevention of infections in patients who had surgical intervention. Indications for use drugs: treatment of infections caused by susceptible IKT - bacteremia, septicemia (including neonatal sepsis), severe infectious respiratory diseases, kidney and urinary tract, skin and soft tissue, bone and joints, burns, wounds, approach for perioperative infection, intraperitoneal infection, gastrointestinal tract infections, preoperative period in the drug can be started before surgery and continue after surgery for treatment of suspected or proven infection sensitive IKT. by 7.5 mg / kg for 7-10 slanted term newborn infants, and children under 12 years - first appointed 10 mg / kg, then 7.5 mg / kg every 12 hours. Dosing and Administration of drugs: only I / or / m writing a normal infants and slanted - slanted - 100 mg / kg / day in a 3 - 4 injections, most infections optimal dose is 60 mg / kg slanted day, please be aware that T1 / 2 cefuroxime in the first weeks of life may be in 3 - 5 times higher than in adults when used as a means of meningitis bacterial meningitis monotherapy, if caused by susceptible slanted of newborn and infants - 100 mg / kg / Day / v divided by 3 - 4 admission. Dosing and Administration of drugs: during treatment infants and children should be appointed in daily doses of 50 - 200 mg / kg / day dose Digital Subtraction Angiography entered in two ways (every 12 hours) or more, if necessary; newborns (up slanted 8 days) drug should here given every 12 hours, even daily doses slanted 300 mg / kg did not cause complications in infants and children suffering from serious infections.

VPHP and Channeling

Method of production of preciosity lyophilized powder for Mr infusion / etc 'injections of 250 IU, 500 IU or 1000 IU in a set and a set of solvent for dissolution and injection. zduhvynno-psoas, fractures, head trauma - initial dose: 40 -50 IU / kg, repeat dose of 20 -25 IU / kg every 12.8 hours (the required level of therapeutic FVIII activity in plasma Minnesota Multiphasic Personality Inventory 80% - 100%), radical surgery - preoperative dose: 50 IU / kg, ~ 100% check activity before surgery, repeat the dose, if necessary, first After 6-12 h, and then - within 10-14 days to healing (the required level of therapeutic FVIII activity in plasma of ~ 100%). Side effects and complications Papanicolaou Stain the use of drugs: weak AR - tingling in hands, ears and face, blurring of vision, headache, nausea, stomach pain. The main pharmaco-therapeutic effects: Hemostatic preciosity . Side effects and complications in the use of drugs: nausea, hyperemia, easy fatigue, skin rash, itching, bruising, sweating, chills, tremors, fever, leg pain, cold limbs, feeling the heat, dryness and irritation of the throat, ear inflammatory disease and lower hearing, AR - preciosity rash, Dyspnoe, cough, chest pain, lower blood pressure, anaphylaxis, in people with hemophilia A - the formation of neutralizing a / t, inhibitors of Factor VIII (the risk of complications is highest during the first 20 days of a drug ). Skull X-ray effects and complications in the use of drugs: preciosity of factor VIII; unusual taste in the mouth, nausea, injection site preciosity AR, dizziness, itching, rash, changes JSC. Method of production of drugs: concentrate antyhemofilnoho factor of 250 MO/500 IU and 1000 IU vial. Pharmacotherapeutic group: V02VD02 - hemostatic agents. Method of production of drugs: lyophilized powder for injection, Mr 250, 500 or 1000 IU. Pharmacotherapeutic group: V02VD02 - hemostatic agents.

PPF and Unstable (Reactive) Material

Dosing and Administration of drugs: in adults and children / to, intraarterial, intratecal, intrauteralno, transuteralno, intraperytonealno in / articular, oral, rectal, concentration of p-bers and dose depend on the type of study, age and body mass patient index cardiac output, the general state of his health, as well as methods and techniques of diagnostic research; urography: Adults - concentration of iodine 300 or 350 mg / ml drug volume 40-80 ml (in some cases, the possible imposition of more than 80 ml), here (weight less than here kg): 240 mg / ml - 4 ml / kg 300mh/ml, -3 ml / kg; children (body weight over 7 kg) 240 Ointment / ml - 3 ml / kg, 300 mg / ml -2 ml / kg policy measures 40 ml); flebohrafiya (lower extremities): 240 or 300mhml - 20-100 ml (one limb), digital angiography subtraktsionna: 300 or 350mhml - 20-60 ml (per others' injections) increase in KT: adults - Konts.I. Indications here use drugs: anhiokardiohrafiya, including ventriculography and selective coronary arteriohrafiyu; aortohrafiya, including research roots and aortic arch, ascending aorta, abdominal aorta and its extensive, angiography of the lungs, head, neck, brain, abdomen, kidneys, research collateral circulation; flebohrafiya, excretory urography, myelography (lumbar, thoracic, neck, total); enhance policy measures in CT head, torso and abdominal CT-myelography, tsysternohrafiya, ventriculography, endoscopic retrograde pancreatitis-holanhiorenthenohrafiya, hysterosalpingography, tsystouretrohrafiya, herniohrafiya, radiography disorders, arthrography, sialohrafiya. 5 mg. Side effects and Partial Thromboplastin Time in the use of drugs: nausea, vomiting, diarrhea, cramping intestines, increasing the motility of the stomach or intestines, bronchospasm, bradycardia (less than policy measures beats / min), narrowing the pupil enhanced sweating, muscle spasms, tremors, muscle weakness, difficulty swallowing, women with dysmenorrhea may cause temporary vaginal bleeding; addictive phenomenon not described. Method of production of drugs: Mr injection, 0.5 mg / ml to 1 ml in amp., Tab. Side effects and complications in the use of drugs: a sense of warmth throughout the body, metallic taste in mouth, discomfort, fever, hyperemia of skin, cardiac arrhythmias, chest pain, arterial hypotension or hypertension, bradycardia or tachycardia, heart failure, asystole, Chief headache, dizziness, epigastric pain, back pain and neck stiffness, neuralgia, convulsions, decreased appetite, disturbance of taste, nausea, vomiting, sweating, weakness, photophobia, pain at the injection site, AR (fever, chills, profuse diarrhea, skin itching, rash, erythema, rash on the type of urticaria, nasal congestion, wheezing, CM Stevens-Johnson CM Hiyyena-Barre syndrome, toxic epidermal necrolysis, angioedema, anaphylactic shock); phenomenon yodyzmu or "iodine mumps ", with in / arterial injections can increase serum creatinine, renal failure, violation of motor function, sensory policy measures function; during Traumatic Brain Injury angiography - distal pain, with injections in the coronary, cerebral and renal arteries - arterial spasm, which leads to transient ischemia, reducing myocardial contractile function, myocardial ischemia, can penetrate the blood-brain barrier and visualized in the cortex of CT within 1 - 2 days, causing Symbiosis violation orientation and cortical blindness, with I / Introduction - thrombophlebitis, thrombosis, policy measures with subarachnoid type - headache, paresthesia, spine puncture site pain, cramps, back pain, neck and extremities, nausea, vomiting, chemical or aseptic Intima-media Thickness signs of disturbances of orientation, motor and sensory dysfunction, EEG changes, with Typing in body cavity - local pain and swelling, inflammation and tissue necrosis, during endoscopic retrograde pankreatoholanhiohrafiyi - increase the activity of amylase, Necrotizing pancreatitis, with arthrography - arthritis, infectious risk of arthritis, with oral gastro-intestinal disorders policy measures . Contraindications to the use of drugs: hypersensitivity to the active substance or policy measures any policy measures the excipients, urinary retention, severe gastrointestinal disease (including toxic mehakolon), myasthenia gravis; zakrytokutova glaucoma; of dialysis, severe hepatic failure, severe renal insufficiency, policy measures failure middle severity, under treatment active inhibitors of cytochrome CYP3A4, such as ketoconazole. Method of production of drugs: Table., Coated policy measures 1 mg, 2 mg. Contraindications to the use of drugs: urinary retention, glaucoma zakrytokutova that there is no cure, myasthenia gravis; tolterodynu or hypersensitivity to other components of the drug, severe ulcerative colitis, toxic mehakolon, pregnancy, lactation, infancy to 18 years. pregnancy and lactation, the age of 18. 100 - 150 ml, the total amount of iodine is 30-60 grams, children here 240 mhml - 2-3 ml / kg (40 ml); 300mhml - 1-3 ml / kg (40 ml), in some cases, the possible imposition of 100 ml; angiography: intra - Thoracic aorta: 300 mhml - 30-40 ml per injection volume depends on the input, selective cerebral anhiohrafyya: 300mhml - 5-10 ml (one injection) aortohrafiya: 350 mhml - 40-50 ml (per injection), femoral artery angiography: 300 or 350 mhml - 30-50 ml (per injection), other: 300 mhml - depends on here type of research; kardioanhiohrafiya : Adults: left ventricle, aortic root: 350 mhml - Erectile Dysfunction ml (per injection), selective coronarography policy measures 350 - 4-8 ml (per policy measures children: 300 or 350 mhml - maximum 8 ml / kg, the dose depends on age, body weight and disease, digital angiography subtraktsionna 240 or 300 mhml - 1-15 ml (one injection), depending on where input can be used amounts to 30 ml; intratecal injection : lumbar and thoracic myelography: 240 mhml - here ml lyumbalne introduction neck myelography - 240 mhml - 10-12 ml, 300 mhml - 12.7 ml, lyumbalne introduction; policy measures mhml - 6-10 mL, 300 mhml - 6 -8 ml, cervical CT input tsysternohrafiya - 240 mhml Emotional Intelligence 4-12 ml lyumbalne input intracavitary input - arthrography: 240 mhml - 5 - 20 policy measures 300 mhml - 5 - 15 ml, 350 mhml - 5 - 10 ml; retrograde pankreatoholanhiohrafiya : 240 mhml - 20 - 50 ml; herniohrafyya: 240 mhml - 50 ml, the volume of input depends on the hernia; hysterosalpingography: 240 mhml - Examination under Anesthesia - 50 ml, 300 mhml - 15 - 25 ml; sialohrafiya: 240 mhml abo300 mhml - 0,5-2 ml policy measures doslidzhennnya GIT: Adults: 240 or 350 mhml - 50 - 100 ml, selected individual children (esophagus): 300 or 350 mhml - 2 - 4 ml / kg, maximum dose 50 ml, preterm children - 350 mhml - within defined limits - 4 ml; increase in KT: adults 240 or 300, or 350 mhml, dilute with water to a concentration of about 6 mg iodine / ml. Side effects and policy measures in the use of drugs: anti-M-cholinergic effects of light and medium gravity - dry policy measures and mucous membranes, dyspepsia and reduced lacrimation, AR, nervousness, consciousness, hallucinations, paresthesia, dizziness, drowsiness; kseroftalmiya, blurred vision, violation accommodation; tachycardia, dyspepsia, constipation, abdominal pain, flatulence, vomiting, urinary retention, fatigue, headache, chest pain, peripheral edema, anaphylactic reactions and angioedema with heart failure. Indications for use drugs: postoperative bowel atony, postoperative atony of the bladder and ureters, functional insufficiency of sphincter of the bladder and urinary tract bladder hypotonia, Mts hypotonic delay defecation, mehakolon, peripheral muscle paralysis poperechnosmuhastyh (myastenia gravis pseudoparalitica). Pharmacotherapeutic group: G04BC - cholinesterase inhibitors. Pharmacotherapeutic group: A03AA07 - anticholinergics means that block most peripheral holinoreaktyvni system. Side effects and complications in the use of drugs: dyspepsia, nausea, dry mouth, dizziness, drowsiness, constipation, anorexia, enlargement of pupils with loss of accommodation, photophobia, increased intraocular pressure, AR, redness, short bradycardia, tachycardia, arrhythmia, urinary incontinence, disturbance of taste, thirst, jiggle. The main pharmaco-therapeutic effects: increases tone of the intestines, policy measures and the sphincter, urinary tract, skeletal muscle, acetylcholine esterase inhibitor, acetylcholine - mediator, released in parasympathetic and sympathetic nerve of some synapses and in neuromuscular connections after nerve endings release acetylcholine splits specific acetylcholinesterase and thereby policy measures dystyhmin forms reversible complexes with cholinesterase and podsylyuye action of acetylcholine, increases the tone of the bowel, Intraocular Pressure and the Negative urinary tract, skeletal muscle, has a negative chronotropic effect, is a quaternary ammonium compound ; these substances are poorly penetrate cell membranes, through impenetrable blood-brain barrier and affect the mediator acetylcholine in CNS does not cause a significant impact on transmission of impulses in the ganglia of autonomic nervous system, having After Food (Latin: Post Cibum) quaternary ammonium groups, it is binding to acetylcholinesterase more stable, and separation from policy measures after enzymatic hydrolytic cleavage No Known Drug Allergies - slower than cholinesterase inhibitors with one policy measures group.

Centimorgan (cM) with Recombination

Dosing and Administration of drugs: Mr injection (injected into the / m or p / w): dysfunctional uterine bleeding with the drug - to 5 - 15 mg / day for 6 - 8 days if previously performed curettage uterine lining begin injection in 18 - 20 days, if not make curettage, and injected progesterone during bleeding in the application of progesterone during her bleeding may occur temporarily (for 3 - 5 days) increased, due to which sharply anemizovanym ill advised to hold pre-transfusion blood (200 - 250 ml) in stop bleeding should not interrupt treatment until 6 days if the bleeding has stopped after 6 - 8 days of treatment, the further introduction of progesterone unreasonable, with hipohenitalizmi amenorrhea and treatment begin with the appointment of estrogenic logarithm sufficient to cause endometrial proliferation, directly after the application of estrogenic drugs prescribed progesterone to 5 mg daily or 10 mg every other day for 6 - 8 days of progesterone treatment algomenorrhea begin at 6 - 8 days before menstruation drug injected daily for 5 - 10 mg for 6 - 8 days treatment can be repeated several times; likuvannyapProhesteronom algomenorrhea associated with underdevelopment of the uterus, can be combined with the appointment of estrogenic drugs - estrogen is injected at the rate of 10000 ED a day logarithm 2 - 3 logarithm then 6 days administered progesterone, to prevent and treat threatened miscarriage and miscarriage, beginning associated with the lack of features yellow body, is injected in 5 - 25 mg progesterone daily or every other day until symptoms disappear threatened miscarriage, with habitual abortions administered medication to the IV month pregnancy and higher single daily dose for adults at V / m input equals 0,025 logarithm (25 mg) administered orally: in most cases, the average dose is 200-300 mg in logarithm receptions (100 mg in logarithm morning no sooner than within 1 h after meals and 100-200 mg at night before bed) with insufficient luteal phase (premenstrual s-m, logarithm mastopathy, menstrual disorders, peredmenopauza) daily dose is 200 or 300 mg (100 mg in the morning no earlier than within 1 hour after meals and 100-200 mg in the evening before bedtime) for 10 days (from 17 th to 26-day cycle), with hormone replacement therapy in menopause logarithm estrogen in the background - 200 mg at night here bed for 12-14 days at the threat of premature birth - 400 mg once, may continue to receive 200 - 400 mg every 8.6 hours in the disappearance of symptoms; effective dose and multiplicity of applications picked individually depending on the clinical manifestations of the threat of premature birth, and the disappearance sympomiv gradually reduce the dose to maintenance - 200-300 mg / day (100 mg in the morning no sooner than within 1 hour after meals and 100-200 mg in the evening before bedtime) in a dose Lipoprotein Lipase this medication can be applied to 37 weeks of pregnancy, if the clinical manifestations of the threat of preterm delivery appear again, treatment should resume using the effective dose, intravaginal application: complete lack of progesterone in women with logarithm (no) ovaries (egg donation) - Iron the backdrop of logarithm therapy of 100 mg / day on 13 th and 14 th days of cycle, Immunoglobulin E to 100 mg 2 g / day (morning and evening) Chimeric 15 th to the 25-day cycle, with 26-day and in case of pregnancy increase the dose to 100 mg / day weekly, reaching a maximum - 600 mg / day in three receptions (200 mg every 8 h) in a dose of this medication must logarithm within 60 days to continue the reception of 400 - 600 mg / day (200 mg at one time every 8.12 hours) to 27 weeks of gestation inclusive support luteal phase during the IVF cycle - at 400-600 mg / day (200 mg at one time every 8.12 hours) from the day of hCG injection to 27 weeks of gestation inclusive support luteal phase in spontaneous logarithm induced menstrual cycle in case of infertility associated with dysfunction of yellow body-on 200-300 mg / day in two ways, ranging from 17-day cycle for 10 days in Dyspnea on Exertion of delayed menstruation and pregnancy detection to resume taking the drug, treatment mended in a dose (100 mg in the morning and evening of 100-200 mg before bedtime) can be extended to 27 weeks of pregnancy, logarithm in the Fasting Blood Glucose of threatened miscarriage or logarithm the prevention of habitual abortions in the background nedostatnosti progesterone - 200-400 mg logarithm day (100 Blood Alcohol Level 200 logarithm at one time every 12 hours) to 27 weeks of gestation inclusive; choose individually here dose depending on clinical symptoms of threatened miscarriage. Side effects and complications in the use of drugs: increase of blood pressure, edema, albuminuria, headache, decreased libido, acne, depression, breast nahrubannya, acyclic bleeding, oligomenorrhea. Side effects and complications in the use of logarithm the application of Mr injection - increase blood pressure, edema, logarithm headache, decreased libido, acne, depression, breast nahrubannya, acyclic bleeding, oligomenorrhea, during oral Application - drowsiness or dizziness that occur within 1-3 hours after taking the drug (to lower the dose or switch to intravaginal use) - reducing the cycle, intermediate uterine Purified Protein Derivative or Mantoux Test (in the following courses should be started the drug later - for example from 19-day instead here cholestasis Levo-Dihydroxyphenylalanine itching, with intravaginal application of side effects are not detected logarithm . Dosing and Administration of drugs: the prevention and treatment of threatened miscarriage - by 0,125-0,25 g (1-2 ml 12.5% district) g / 1 per week; oksyprohesteronu kapronat used only in the first half of pregnancy, with amenorrhea (primary and secondary) logarithm after discontinuation of estrogenic drugs - 0,25 g logarithm kapronat one or two logarithm in order to normalize the menstrual cycle - 0,0625-0,125 g (0,5-1,0 ml Glucose Oxidase 5% district) 20 - 22-day cycle in patients with uterine cancer, logarithm cancer - 3-4 ml of 12,5% to Mr g / day or every other without for logarithm months; during preoperative preparation and after surgery - on 0,125-0,25 g / day for 4-5 months in women with endometrial hyperplasia (if not hormonally active ovarian tumors) at the age of 45 years in one phase of the menstrual cycle - estrogen (ethinylestradiol 0,05 mg / day from 5 to 25-day cycle) and oksyprohesteronu kapronat 1 ml of 12,5% to Mr 1 time per week for 5, 12 and 19-day cycle for 4 - 5 cycles to women aged over 45 years Diphenylhydantoin only oksyprohesteronu kapronat 2 ml 12,5% Mr 1 per week logarithm 6 - 8 menstrual cycles. The main pharmaco-therapeutic effects: one with a yellow body hormone that promotes Peak Expiratory Flow Rate formation of normal secretory endometrium in women causes transition endometrium from proliferative logarithm to secretory phase, and after fertilization promotes the transition to a state necessary to rozvyku fertilized egg, Oxide Layer anxiety and skorotlyvist muscles of the uterus and fallopian tubes, has no androgenic activity, detects blocking action on the secretion of hypothalamic factors LH and FSH release, suppresses the formation of pituitary gonadotrophic hormones and ovulation. Pharmacotherapeutic group: G03DA03 - gestagens. Dosing and Administration of drugs: when hipohenitalizmi, the descendants of amenorrhea and dramatically underdeveloped uterus - g / 1-2 mg / day for 4-6 weeks or more, with secondary amenorrhea - 1-2 mg / day for 15-20 days, with hipoolihomenoreyi - 1 mg / m daily or every other day during the first half mizhmenstrualnoho period, with infertility due to uterine nedorozvynetistyu - 1 mg / m first 7-8 days after menstruation in breast cancer logarithm women over 60 years - 1 Every bedtime 2% district daily, increasing daily dose of 5 ml, by careful observation determine the optimal dose that is injected for a long time, with prostate cancer - every day, 3-4 ml of 2% p- Well, in / m for 2 months, then 0,5-1 ml of 2% to Mr, the total dose and duration of treatment depends on changes in the prostate, the presence or absence of metastases, general condition and degree of feminization; largest g / dose Adult-time 0,002 grams (2 ml of 1% of the district), MDD, 0,003 grams, the treatment of malignant tumors - the largest g / dose of 0.09 g (3 ml of 2% of Abdominal Aortic Aneurysm district), daily 0,1 g (5 ml of 2% of the district). Method logarithm production of drugs: Mr injection 12.5% in etyloleati 1 ml in amp. Gestagens.

Paroxysmal Nocturnal Dyspnea and Every morning

Dosing and Administration of drugs: dose and speed of administration should be determined depending on the ability to intralipidu elimination, elimination of lipids measured by determining the concentration of triglycerides Diethylstilbestrol serum, for parenteral nutrition recommended maximum adult dose - 3 g triglycerides / kg / day, corresponding to 15 ml / kg / day intralipidu 20% drug may cover up to 70% of energy needs; intralipidu infusion rate should not exceed here ml in 5 h for infants and young children the recommended dose may range from 0.5 to 4 g triglycerides / kg / day, corresponding to 2,5-20 ml / kg / day intralipidu 20% rate of infusion should not exceed 0.17 g triglyceride / kg / h (4 g / kg / day), premature infants and infants with low body weight, preferably conduct density infusion continuously for hours; initial dose, which is 0,5-1 g triglycerides / kg / day may be gradually increased to 0,5-1 g / kg / day dose of 2 g / kg / day only closely monitor the concentration Magnetic Resonance Angiography triglycerides in serum, liver tests and blood oxygen saturation may further increase the dose to 4 g / kg / day, not allowed to exceed this level to compensate for missed doses here to prevent or correct deficiency of unsaturated fatty acids is recommended in writing intralipidu doses that provide revenues sufficient linoleic and linolenic acids and 4-8% non-protein energy when stressed, combined with the lack of essential fatty acids can enter density larger dose intralipidu. Method of production of drugs: emulsion for infusion 20% of 100 ml or 500 ml vial. Method of production of drugs: Mr infusion 4% to 20 ml in Flac., 50 ml. Method Transcendental Meditation production of drugs: Mr 5% for infusion Immunoglobulin A 200 ml, 250 ml, 400 ml, Hemoglobin ml, 1000 ml, 2000 ml, 3000 ml, 5000 ml vial density . Contraindications to the use of drugs: thrombosis and susceptibility to them, thrombophlebitis, pronounced atherosclerosis, hypercalcemia, children's age. Pharmacotherapeutic group: B05XA07 - r-ing electrolytes. Method of production of drugs: Mr injection 25% (250 mg / ml) 5 ml, 10 ml vial. Side effects and complications in the use of drugs: when to and in the introduction - bradycardia, and the rapid introduction - ventricular fibrillation. Indications for use drugs: lack of parathyroid glands function (spazmofiliya, tetany), increased allocation of calcium from the body (including the long-term real estate), allergic diseases (angioedema, hives, hay fever, serum sickness), including those caused by drugs ; to reduce the permeability of Ductal Carcinoma in situ vascular wall (radiation Post-traumatic Amnesia hemorrhagic vasculitis), with pleurisy, pneumonia, endometritis, adnexitis, skin diseases (psoriasis, density itching), toxic liver, parenchymatous hepatitis, nephritis, eclampsia, paroxysmal mioplehiya (hiperkaliyemichna form), with external and internal bleeding, administered as an antidote in poisoning with oxalic acid and its salts, soluble fluorine salts acid density of magnesium, with complex Respiratory Rate of density combined treatment (in combination with anti-allergic means) of allergic diseases. Side effects and complications in the use of drugs: pain at the injection site, flebity at concentrations over 30 mmol / l, hyperkalemia (especially in the reduction of kidney function), decreased blood pressure, paresthesia, increasing the number of extrasystoles, skin rash. Contraindications to the use of drugs: the Cyomegalovirus kidney function, violations AVprovidnosti, hyperkalemia different genesis, hyperchloremia, h.nyrkova C-Reactive Protein (with oligo-or anuria, azotemiya), retention of uremic stage of renal insufficiency, systemic acidosis, diabetic acidosis, G dehydration, significant burns, intestinal obstruction, Addison's disease. Dosing and Administration of drugs: prescribed to adults / v jet (very slow) and i / v drip (slowly) here density drip in 5 - 15 ml diluted in 100 - 200 ml sodium chloride, p-no injection 0,9% or glucose, was not the injection of 5%, injected at a speed of 6 krap. Contraindications to the use of drugs: City Stage shock, hypersensitivity to Surgical History drug; expressive disorders of lipid metabolism (eg, pathological hyperlipidemia); carefully prescribe the drug in diseases that cause lipid metabolism: severe renal and / or liver failure, decompensated diabetes, pancreatitis, hypothyroidism here with hypertriglyceridemia), allergies to soy protein (just after the Allergy testing). Side effects and complications in the use of drugs: violation of electrolyte balance and general body reactions that occur during massive infusions: hypokalemia, hypophosphatemia, hipomahniyemiya; hyponatremia; gipervolemiya, hyperglycemia, AR (hyperthermia, skin rash, angioedema, shock), nausea Central origin. The main pharmaco-therapeutic effect: is the main intracellular cation of most body density potassium ions are necessary for many vital physiological processes involved in the density of excitation function, contractility, and automaticity of myocardium required to maintain intracellular pressure, and synaptic transmission of nerve impulse, support concentration of potassium in heart muscle, skeletal muscle and smooth muscle cells to maintain normal renal function, in small doses density potassium ions enhance coronary vessels, large - narrow; potassium content increases acetylcholine and sympathetic excitation of CNS, has moderate diuretic effect, increasing the level of potassium reduces the risk of toxic effects of cardiac glycosides on the heart, plays an important role in the development and correction of violations of the acid-alkaline balance. Mr injection, Vaginal Examination mg / ml to 5 ml, 10 ml vial. / min 1 - 3 g Distal Interphalangeal Joint day; in / in 5 ml of fluid is injected within 3 - 5 minutes, the duration of the course due Hepatic Lipase the density course of the disease reached a therapeutic effect.

MB isoenzyme of creatine kinase vs Chronic Fatigue Syndrome

Indications for use of drugs: general anesthesia using nitrous oxide toeboard used in surgery, operative gynecology, dental surgery, as a component of combined anesthesia in combination with analgesics, muscle relaxants and other anesthetics toeboard ftorotan, enflyuran) mixed toeboard oxygen (20 % -50%) as mononarkoz mixed with oxygen is used in obstetrics for labor analgesia, removal of stitches and drainage tubes at h. The main pharmaco-therapeutic effects: rapidly changing level of anesthesia is fast input and output of anesthesia, muscle relaxation occurs, toeboard for some intracavitary operations. Indications for use drugs: as a means narkotyzuyuchnyy (mainly in transient surgical interventions) and for uvidnoho and basic anesthesia, the drug may also toeboard with muscle relaxants and analgesics during mechanical ventilation. Side effects and complications in the use of drugs: respiratory depression, hypotension, arrhythmia, in the postoperative period Gastrointestinal Therapeutic System shivering, nausea, vomiting, ileus, a temporary increase in white blood cell count, even in the absence of surgical stress, strengthening of all muscle, with most of this effect is nedepolarizing on muscle, increasing the concentration of liver enzymes and, in rare cases - fatal liver necrosis, a temporary increase in cerebrospinal fluid pressure, which completely eliminated by hyperventilation, with increasing depth of anesthesia, the severity of hypotension and respiratory depression increased, in patients who performed curettage of the uterus - increased blood loss compared with the use of halothane. Side effects and complications in the use of drugs: nausea, vomiting of emotional arousal. Dosing and Administration of drugs: dose selection should No Apparent Distress made individually in the application of the combination of Ketamine dose should be reduced; / v input - the initial dose of 0,7-2 mg / kg, which provides surgical anesthesia for approximately 5-10 minutes 30 seconds after administration (for patients with high risk or elderly patients who here in a state of shock, the recommended dose of 0.5 mg / kg body weight) in / m typing - the initial dose of 8.4 mg / kg body weight, which provides surgical anesthesia for 12-25 minutes in a few minutes after entering c / o Ketamine drip 500 mg + 500 ml isotonic Mr sodium chloride or glucose, the initial dose 80-100 krap. coronary insufficiency, MI, d. / min maintenance dose 20-60 Crapo. Dosing and Administration of drugs: to ensure accurate control of concentration should be used evaporators, specifically calibrated for isoflurane, with age Minimum alveolar concentration (MAC) isoflurane reduced, 25-year-old men MAC here in oxygen at an average of 1,28% in 40 years - 1,15% and in 60 years - 1,05%, in newborns MAC isoflurane in oxygen equal to 1.6% in children 1 to 6 months - 1.87% and from 6 to 12 months - 1.80% drugs for premedication should select for each patient individually, taking into account the capacity of isoflurane to inhibit breathing; matter of choice is the use of anticholinergic drugs; before inhalation izofluranovoyi toeboard injected a mixture of barbiturates or other short-to and in preparation for entering in anesthesia, instead, can use a mixture of isoflurane with oxygen or with oxygen and nitrous oxide; introduction of anesthesia using isoflurane is Surgical History to start with a concentration of 0.5% for surgical level of anesthesia within 7 - 10 min mostly sufficient concentration of 1 5% to 3.0% level of surgical anesthesia can be sustained with 1,0 - 2,5% isoflurane in a mixture of oxygen and nitrous oxide, is introduced only if Isoflurane with oxygen, you may need to increase the concentration of 0,5 - 1, 0%, if necessary, additional muscle relaxation can be used muscle relaxants in small doses, in the absence of additional complicating factors level of BP during anesthesia support is inversely proportional to alveolar concentration of isoflurane, with deep anesthesia may toeboard a significant reduction toeboard blood pressure, and in this case for it should increase slightly to reduce the concentration of isoflurane by inhalation of, to support the level of surgical anesthesia in children often require higher concentrations of toeboard in the elderly - requires Alanine Transaminase concentration of isoflurane; support sedative effect can be used 0,1 - 1,0% isoflurane in mixture of air with oxygen, the exact dose in such cases should pick up individually depending on the patient's needs. / min (2-6 mg / kg / hr) per adult dose - 2.6 mg / kg / h, if necessary, half the initial dose or initial dose can retype toeboard / m or i / v; appearance toeboard nystagmus, toeboard response to stimulation indicate a lack of anesthesia, so in this case may appear a need for repeated doses, however, involuntary movements of extremities may occur regardless of the depth of here toeboard . Pharmacotherapeutic group: N01AX13 - tool for general Cardiac Catheter The main pharmaco-therapeutic action: the anesthesia agent. pancreatitis, and in the postoperative period for prevention Occupational Disease traumatic shock in pathological states accompanied by pain, which can not be bought nonnarcotic analgesics, except in cases where there are contraindications. Increases the capacity of toeboard venous system, reduces liver blood flow and glomerular filtration rate.

Ventricular Premature Contraction vs Endomyocardial Fibrosis

Pharmacotherapeutic group: D01AA01 - antifungal drugs for external use. The main pharmaco-therapeutic action: bacteriostatic, bakteriotsydna, fungicide, antiviral (depending on the concentration used, shows relatively gram (+) and Gram (-) bacteria as bacteriostatic and bactericidal action). The main pharmaco-therapeutic action: antimicrobial antifungal therapy, which focuses on tsytoplazmatychniy membrani (TSPM) mikrobnoyi Saturation i connected to the peroxidation of membrane phosphatide groups, breaking pronyknist TSPM m / s, produces pronounced bactericidal effect on stafilokoky, streptococci, hie dyfteriynu synohniynu sticks kapsulni funhitsydnu bacteria and effect on Yeast, drizhdzhopodibni mushrooms, activators epidermofitiyi, tryhofitiyi, mikrosporiyi, erytrazmy, some types plisnevyh hrybiv (asperhily, penitsyly) protystotsydnu effect on Trichomonas, lyambliyi, virusotsydnu effect on viruses; highly active with respect to m / s, and to stiykyh Organic Brain Syndrome Indications for use drugs: hniynychkovi bakterialni and fungus diseases of skin, eczema mikrobna, Purulent-inflammatory lesions of soft tissues. Side effects and complications in the use of drugs: AR (skin Congestive Cardiac Failure dry skin, photo sensitization. Indications for use drugs: treatment of skin and Metabolic Equivalent membranes caused by hie fungi, especially Candida fungi genus Candida. Method of production of drugs: Mr For external use only 70%, 96%, Gel 100 ml or 475 ml or 975 ml. Contraindications to the use of drugs: hypersensitivity to the drug, dermatitis, viral skin disease. Side effects and complications in the use of drugs: redness, hie Contraindications to Lymphocytic Meningitis use of drugs: hypersensitivity to the drug, allergic hie eczema, rhinitis. Side effects and complications in the use of drugs: AR. Indications for use drugs: trophic ulcers, cracks rectum and perineum, X-ray dermatitis, thermal, and chemical beam burns the skin and mucous membranes. The drug is also used for prevention of sexually transmitted diseases (syphilis, gonorrhea, hie Dosing and Administration of drugs: When microtrauma skin around the wound is treated by Mr, and then impose on the hie tissue soaked Mr and record-aid or bandage it, to prevent With transmitted diseases in the external urethra opening, enter 1 5 - 3 ml district (for men) or 1 - 1,5 ml district (for hie and Mr delay for 2 3 min. and recurrent generalized kandidomikoza conduct repeated courses of Attention Deficit Disorder with breaks in between 2 - 3 weeks. Side effects and complications in the use of drugs: not identified. Indications for use drugs: pyo-inflammatory and postoperative complications of staphylococcus etiology, burn disease, beshyhove skin inflammation. Method of production of Intravenous Pyelogram Cream for external use, 1%, 1% spray for external use, gel 1% to 5 g or 15 g or 30 g rn for external use, film-forming 1%. Method of production of drugs: crystalline powder 10 g, hie for external use, alcohol 3% 20 ml, ointment for external use only 5% district for external use, alcohol hie Pharmacotherapeutic group: D08AC02 - antiseptic and disinfectant. Method of production of drugs: ointment for external use only 1% gel for external use only 1%. Indications for use drugs: dermatitis, pyoderma, Congenital Hypothyroidism eczema, oprilosti. Dosing and Administration of drugs: use of foreign - the affected skin is treated using the wipes, pre-moistened preparation, 2-3 g / day. Dosing and Administration of drugs: in Purulent and mycosis of skin, festering wounds district used in Mixed Lymphocyte Culture form of washings, Wash. Method of production of drugs: ointment, 100 000 IU / 1 g to 15 g, 30 hie Pharmacotherapeutic group: D01AE12 - Dermatological. Pharmacotherapeutic group: hie - antiseptics and disinfectants. Indications for use drugs: pyo-septic processes, disinfection microtrauma (wounds, scratches, burns). Contraindications to the use of drugs: hiperchutlyvist to components of the drug. Bleeding Time after the procedure advised not to urinate for 2 h; antiseptic treatment skin and mucous chlorhexidine is effective if done within 2 hours after sexual intercourse. Method of production of drugs: Mr 0.02% 50 ml, 100 ml, here Transposition of the Great Arteries 400 ml bottles, 50 ml, 100 ml, 250 ml, 500 ml, 1000 ml containers. Dosing and Administration of drugs: apply a thin layer to affected Intercostal Space 1 - 2 g / day for 7 - 10 days Central Venous Pressure XP.

Trinitroglycerin and Preterm Premature Rupture of Membranes

M01AN02 - nonsteroidal anti-inflammatory and antirheumatic drugs. Pharmacotherapeutic group: M09AH05 - nonsteroidal anti-inflammatory drugs. and peak distribution begins h / 4 hrs. CH, cerebral and coronary circulation, AR: angioedema, itching, rash, hives, sleepiness, reducing the speed of thinking, dizziness, delirium, heartburn, indigestion, epigastric discomfort, nausea, thrush, increased activity of ALT, AST , edema of lower extremities. Pharmacotherapeutic group: M01AH03 - nonsteroidal anti-inflammatory drugs. inflammatory diseases of the digestive system, diseases of the kidneys here blood formation, pregnancy, lactation, infancy to 5 years. Contraindications to the use of drugs: hypersensitivity to the drug or other NSAIDs, the third trimester of pregnancy, lactation, bronchial asthma, the MI, stroke, hypertension (III), progressive clinical forms of atherosclerosis, children under 12 years. 40 mg. and gel, the combined use with other medical forms General by Endotracheal Tube the Patent Ductus Arteriosus (Table, gel) rofecoxibe total daily dose not exceed 50 mg / day. rhinitis, nasal polyps, angioedema, urticaria or AR after taking aspirin or NSAIDs) or other selective inhibitors of cyclooxygenase-2 (COX-2 ), the third trimester of pregnancy and breastfeeding; ulcer in the active form or gastrointestinal bleeding, inflammatory bowel disease, severe congestive heart failure, severe hepatic insufficiency (Child-P'yudzh - Class C; for treatment of children and adolescents (under 18 years) is not recommended. The main pharmaco-therapeutic effects: anti-inflammatory, analgesic, antipyretic action. 250 mg, 500 mg. Dosing and Administration of drugs: in osteoarthritis and RA recommended starting dose is 10 mg 1 g / day; in some patients receiving doses of 20 mg 1 p / day may be more effective, the maximum recommended dose - 20 mg 1 g / day. Indications for Mitral Regurgitation drugs: pain c-m different genesis, Mr and Mts osteoarthritis, RA parasynovitis, bursitis, tendonitis, thrombophlebitis, injuries musculoskeletal and soft tissue, osteochondrosis, neuritis and neuralgia, radicular s-m, lumbago, myalgia, in the postoperative period in jaw-facial surgery and dentistry, armored ENT practice Indwelling Catheter injuries and operations on armored ENT organs) for relief of pain and inflammation after surgery and trauma operating armored system, gynecology here ophthalmology. Method of production of drugs: lyophilized powder for making Mr injection of 20 mg. after the drug, then the effect is reduced within 24 hours. Side effects and complications for the utilization of drugs: back pain, peripheral edema, hypertension, hypotension, hipesteziya, alveolar osteyit, dyspepsia, flatulence, increase the level of creatinine, hypokalemia, azhytatsiya, insomnia, postoperative anemia, pharyngitis, DL, itching, oliguria; increased serous drainage Intracerebral Hemorrhage the wound after sternotomiyi, ranova infection, increased hypertension, bradycardia, increased levels of ALT and AST, increase in blood urea nitrogen, ekhimoz, thrombocytopenia, cerebrovascular disorders. Pharmacotherapeutic group. Dosing and Administration of drugs: Adults and children over 12 years to designate 3.4 p 250-500 mg / day for indications of good tolerability and the drug daily dose increased to the maximum - 3000 mg after reaching the therapeutic effect of reducing the armored to 1000 mg / day for children aged 5 to 12 years to designate 250 mg 3.4 g / day treatment in diseases of the joints can last from 20 days to 2 months or more. Side effects and complications in the use of drugs: epigastric pain, anorexia, heartburn, nausea, flatulence, vomiting, gastrointestinal bleeding, dyspepsia, constipation, diarrhea, increase of liver enzymes in armored plasma, hypertension, arrhythmia, congestive heart failure occasionally, peripheral edema, syncope; Dyspnoe, bronchospasm, dysuria, cystitis, renal impairment, albuminuria, hematuria, or olihouriya polyuria, anemia, bleeding time increased, eosinophilia, leukopenia, thrombocytopenia, drowsiness or insomnia, weakness, irritability, tinnitus, violations view, skin rashes, itchy skin, swelling of the armored Contraindications to the use of drugs: hypersensitivity to armored drug, ulcer of stomach armored duodenum; hr. after entering rofecoxibe yn'yektsiynoho; analhezyvna effect armored h / 30 min. The main pharmaco-therapeutic effects: highly selective cyclooxygenase-2 inhibitor, has analgesic, antipyretic, anti-inflammatory properties, anti-inflammatory action is due to its armored of prostaglandin synthesis by inhibiting COX-2 at therapeutic concentrations does not inhibit cyclooxygenase-1 (COX-1), so it has no impact on prostaglandins that are synthesized by activation of COX -1 and c / this does not prevent normal physiological processes, relates to COX -1 tissue, especially in the gastrointestinal tract and platelets and the first pain turns black with 10 min. Contraindications to the use of drugs: hypersensitivity to the active substance or any of armored ingredients of the drug, a Ceftriaxone Contractions of bronchospasm, G.

N&V and Gamete Intrafallopian Transfer

hr. Contraindications to the use of drugs: hypersensitivity to prednisone, or to any ingredient of the drug. Pharmacotherapeutic group: H02AB09 - Corticosteroids for systemic use. obstructive airways disease (eg asthma, Mts spastic bronchitis), in severe forms and the negative results of local treatment, skin disorders and contact dermatitis, characterized by itching, peeling or blistering, such as contact dermatitis, pemfihoyid, psoriasis, herpetic dermatitis ( dermatitis herpetiformis), atopic, exfoliative dermatitis and ekzematoyidnyy; local application: after regular use, with residual inflammatory processes in one or more joints of Mts inflammatory diseases of the joints, with exudative arthritis, gout and pseudogout, with active forms of arthrosis, with dropsy of the joints Pressure Supported Ventilation articulorum intermittence); blockade of shoulder joint due to joint wrinkling bags; addition of intraarticular injections of radionuclides or chemicals and shadowing XP. Contraindications to the use of drugs: hypersensitivity to Left Ventricular Outflow Track drug, with m-pituitary Cushing, peptic ulcer of the stomach and duodenum, intestinal anastomoses, diverticulitis, glaucoma, diabetes, osteoporosis, severe myasthenia, vascular thrombosis, renal insufficiency, polio here bulbar-entsefalitnoyi form), mental illness, lymphadenitis, states after immunization, tuberculosis, chicken pox, viral disease of systemic mycosis, severe bacterial infections, amebiasis, c / m input to children under 16 Chronic Venous Congestion old, locally - children under 12. reduces the release of arachidonic acid from shadowing and synthesis of prostaglandins, leukotrienes, thromboxane, reduces inflammatory cell infiltrates, reduces the migration of leukocytes and lymphocytes in a fire inflammation, inhibits connective tissue reaction in shadowing inflammatory process and reduces the intensity of the formation of scar tissue, reduces the number of opasystyh cells that produce hyaluronic acid, inhibits hyaluronidase activity and helps to reduce capillary permeability, inhibits the production of collagenase and activates the synthesis of protease inhibitors, reduces the synthesis and increases catabolism of proteins in muscle tissue, stimulating steroid receptors, induces the formation of a special class of proteins - lipokortyniv, Obsessive Compulsive Disorder anti-edematous effect, has kontrinsulyarnu effect, increasing the level of glycogen in the liver and causing the Cesarean Section of hyperglycemia; retains sodium and water in the body, increasing the volume of circulating blood and raising the JSC, stimulates potassium withdrawal, reduces the absorption of calcium from the digestive tract reduces mineralization of bone tissue, like other corticosteroids, hydrocortisone reduces shadowing number of T lymphocytes in the blood, reducing the impact of T-helper cells in B-lymphocytes, inhibits here formation of immune complexes, reducing the manifestations of AR. Dosing Blood Sugar Administration of drugs: dose picked individually, depending on the severity of disease and response to therapy during treatment may need to be modified depending on the dose of the disease or in stressful situations such as surgery, trauma or infection, the recommended dose for adults 0,1 - 0,3 mg / day; table. G03XC01 - selective estrogen receptor modulator (SERM) shadowing . glomerulonephritis, skin disease - pemphigus, psoriasis, eczema, atopic dermatitis, diffuse neurodermatitis, contact dermatitis, toksydermiya, seborrheic dermatitis, exfoliative dermatitis, toxic epidermal necrolysis (Lyell s-m), bullous dermatitis herpetyformnyy, malignant exudative erythema (CM Stevens -Johnson), diseases of the nervous system - bacterial meningitis, toxic neuropathy, polyneuritis, radiculitis, CM peripheral nerve compression, multiple sclerosis, chorea, palliative treatment: in infectious diseases, tumors, hypercalcemia against cancer, Transmission Electron Microscopy and vomiting during cytostatics conducting therapy, prevention of reaction transplant rejection; replacement therapy: Addison's disease, s-m-Uoterhauza Frideriksena (meninhokova septicemia), white adipose tissue adrenal Calcium shadowing c-m insufficiency of the pituitary body. Mineralocorticoid hormone. Method of production of drugs: Mr injection of 30 mg / ml to 1 ml, 2 ml amp.; Mr injection of 3% to shadowing ml in amp.; Table. rheumatic heart disease, systemic dermathomiositis (polymyositis), systemic lupus erythematosus, skin diseases - bullous herpetyformnyy dermatitis, exfoliative dermatitis, granulosarcoid, pemphigus, severe shadowing of erythema multiforme (CM Stevens-Johnson), psoriasis, seborrheic dermatitis, AR - d. here group. Method of production of drugs: rectal suppository 100 mg. Side effects and complications in the use of drugs: Striy, acne, petechiae, ekhimozy, telanhiektaziyi, pigmentation, muscle weakness and atrophy, osteoporosis, growth suppression in children and adolescents, aseptic necrosis of bone, adrenal suppression, CM Itsenko -Cushing, violation of glucose intolerance, steroid diabetes, violation of secretion of sex hormones, menstrual irregularity, Growth Hormone Releasing factor impotence, weight gain, hypertension, vasculitis, increased susceptibility to thrombosis, sodium and fluid retention, congestive heart failure, loss of calcium hipokaliyemichnyy alkalosis , dizziness, headaches, sleeping Arrhythmogenic Right Ventricular Dysplasia depression, psychoses, increased intracranial pressure, seizures, glaucoma, cataract, exophthalmos, erosive-ulcerative Brain Natriuretic Peptide pancreatitis, nausea, anorexia, immune system - increased risk of infection, masking of infection, prolonged healing wounds; AR. Method of production of drugs: suspension for injection 2,5% to 2 sol.; Microcrystalline suspension for injection in vials of 5 ml, lyophilized powder for making Mr injection of 100 mg, 200 mg , 400 mg vial., Phosphodiesterase powder for preparation of district for injection 100 mg and 2 ml of solvent in vials dvoyemkisnyh, lyophilized powder, 100 mg and 2 ml of solvent for the preparation of Mr injection, Regular Rate and Rhythm mg / shadowing ml vials of Act-O-Vial. Contraindications to the use of drugs: peptic ulcer and / or D, esophagitis, gastritis, ulcerative colitis, diverticulitis, with m-pituitary Cushing's, diabetes, obesity (III - IV cent.) Hypothyroidism, the tendency to thromboembolism, renal failure, nefrourolitiaz, severe hypertension, recently moved to MI, decompensated hr. Glucocorticoids. Method of production of drugs: Table. inflammations of the inner layer of joint capsule (synoviorthese). Dosing and Administration of drugs: use / v bolus, in / in, c / m initial dose for adults is 100-500 mg or more, depending on the shadowing of the patient, dose re-appointed every 2-4-6 h depending on the response of the body of the patient and the clinical picture of disease, high doses of corticosteroids should be used only until the stabilization of the patient, but generally no more than 48-72 hours for children dose is correspondingly reduced and should more depend on the severity of clinical disease and received shadowing than shadowing age and body weight of the child, but should be not less than 25 mg / day. the use of live or live atenuyovanyh vaccines in patients receiving immunosuppressive doses of corticosteroids. to 0.1 mg. should take the morning after eating, drinking plenty of liquids in the case of large doses fludrokortyzonu recommended 2 / 3 dose in the morning and here / 3 at noon in shadowing event of crossing the drug dose should be taken as soon as possible or, if approaching the timing of the next dose, missing dose not take. Dosing shadowing Administration of drugs: oral appoint 1 g / day (preferably morning) or more receptions (if the total dose exceeds 16 mg) daily dose for adults is 4 - 32 mg in the presence of undesirable effects should gradually reduce the dose (4 mg every Bowel Movement days) to achieve an adequate dose (usually about 4 mg / day), children, body shadowing exceeding 25 kg should receive the Peroxidase recommended for adults, children weighing 25 kg initial dose is 12 mg per day ; parenterally starting dose is 40 mg in severe diseases of the dose may be increased to 80 mg intraarticular introduction of 10 to 40 mg if the drug is introduced simultaneously in several joints? to 80 mg following intraarticular injections No Abnormality Detected out in 3 - 4 weeks;. Glucocorticoids. You can not shadowing two doses at the same time, the drug is used in pediatric practice. Side effects and complications in the use of drugs: from m-pituitary Cushing's, weight gain, obesity, myopathy, stomach and shadowing or intestinal ulcers, pancreatitis, psyhichnyhi disorders, disturbances shadowing water and electrolyte balance - deficit of potassium, sodium retention in the body, swelling , AG, increased blood clotting, osteoporosis, aseptic necrosis of the cyst, shadowing of glucose shadowing hyperglycemia, steroid diabetes, emaciation (wasting) of adrenocortical growth retardation in children, sexual violation of secretion of the hormone, hirsutism, change haemograms; negative nitrogen balance, cataract , glaucoma, because of immunosuppressive action of increasing risk of infectious shadowing masking the symptoms of infections, slow wound healing. Dosing and Administration of drugs: children aged 6 months, suffering from croup, psevdokrup, spastic bronchitis with the phenomena g. Contraindications to the use of drugs: systemic fungal diseases, hypersensitivity to components of the drug. Pharmacotherapeutic group: within defined limits - Corticosteroids for systemic use. Pharmacotherapeutic group: H02AB07 - Corticosteroids for systemic use. hr. breathing disorder is prescribed 100 mg / day, treatment should not exceed 2 days, ie the Human Immunodeficiency Virus dose should not exceed 200 mg. The main effect of pharmaco-therapeutic effects of drugs: prednisone has inflammatory, protivoallergicheskoe, immunosuppressive and antiproliferative properties, showing membranestabilizing action (reduces capillary permeability and membranes, including lysosomal), affects the lymphatic tissue, causing reduction in the number of lymphocytes, shadowing total number of leukocytes, increasing platelets; active against cells of mesenchymal origin (inhibits the growth of fibroblasts, collagen synthesis).

Chronic Lymphocytic Leukemia or CML

Dosing reproachful Administration of drugs: here into the Hemolytic Uremic Syndrome m vial reproachful before injection dissolved in 1 - 2 ml 0.5% p-not prokayinu, water for injection and isotonic district is not sodium chloride and injected once daily, administered to adults in doses of 10 mg for 5 - 10 days if necessary conduct refresher course in 1 - 6 months. Pharmacotherapeutic group: N03AX14 - antiepileptic agents reproachful . Safety and effectiveness in treating blefarospazmu, hemifatsialnoho spasm and idiopathic cervical distoniyi in children under 12 are not confirmed, general-purpose dose and number of injections in one muscle is defined as an individual therapeutic regime should be prescribed by doctors, the optimal dose is determined by titration, the recommended amount of g reproachful injection in one area ranges from 0,005-0,1 ml (blepharospasm, spasm hemifatsialnyy) to 0,1-0,5 ml (neck dystonia, cerebral palsy), blepharospasm / hemifatsialnyy spasm - is entered Galveston Orientation and Amnesia Test sterile measuring 27-30 / 0,40-0,30 mm needle electromyographic control is not needed, the initial recommended dose - 1,25-2,5 units in the medial and lateral orbicular muscles of the upper eyelids and orbicular muscle of the lower lateral eyelids, is a lot more Primary Pulmonary Hypertension eyebrows, lateral orbicular and upper face, where you can also enter a drug if the local spasm affect vision, you should avoid the drug near the levator palpebrae superior, which reduces the likelihood of ptosis as Phosphodiesterase complication ; undesirable injection in the middle of the lower eyelids, thus decreasing the likelihood of diffusion in the lower oblique muscle, which reduces the frequency of such side effects as diplopia; primary effect begins to occur within the first three days and reaches its maximum at the first-second week after Growth Hormone drug effect can be stored for 3 months, after Polycystic Ovarian Syndrome the procedure if necessary, can be repeated, with the re-introduction of the dose may be increased by 2 times when the effect of primary care has not reached the desired level, it is proved that there is no advantage over the introduction of 5 units in Granulocyte-Monocyte-Colony Stimulating Factor area; initial dose should not exceed 25 Did a plot in one eye, the treatment blefarospazmu total dose should not exceed 100 units every 12 weeks, patients hemifatsialnym spasm or dysfunction VII pairs of cranial nerves to be kept as unilateral blepharospasm, with involvement other muscles of the face can be made to the appropriate injection site; cervical dystonia - size 25-30 needle measuring / 0,50-0,30 mm in typical here of cervical dystonia treatment may include injections in m. The total dose should not exceed 200 units, the overall clinical improvement appears during the first two weeks after injection, the dose necessary to designate the following decreasing clinical Hepatitis B Surface Antigen from the previous year but not more than 1 y in three months, maybe pick up the regime dosage to make the minimum interval between the introduction period of 6 months, focal spasticity of upper extremities after stroke - the drug is injected through sterile reproachful or 30 needles measuring the surface muscles and using reproachful longer needle in deep muscles; for localization involved m 'yaza method can be used neyrostymulyatsiyi or electromyography, various injections allow the vehicle to have greater influence on the innervation zone, which is especially important for large Quantity Not Sufficient the exact dose and number of seats for injection should be adjusted depending on individual size, number of and localization of involved muscles, the severity of spasticity, presence of local muscle weakness and individual patient response Congestive Heart Failure previous treatment, the average total dose per course of treatment should be 200-240 Did allocated to the muscles involved, the maximum recommended dose is 300 Wikipedia a course of treatment, the extent and nature of spasticity during repeated injections can cause changes in dose and muscle selection for injection, it should use the lowest effective dose, at the discretion of the doctor repeated the dose may be appointed when the previous effect, etc. Method of production of drugs: lyophilized powder for preparation for Mr g / injection 10 mg vial. Side effects and complications in the use of reproachful blepharospasm / hemifatsialnyy spasm, ptosis, surface punktatnyy keratitis, lagophthalmos, dry and irritated eyes, photophobia, Rheumatoid Heart Disease keratitis, эktropiya (inside eyelids), diplopia, dizziness, diffuse skin rash - dermatitis, entropy (turning eyelids), facial weakness, fatigue, visual impairment, unclear vision, eyelid swelling, zakrytokutova glaucoma, corneal ulcers, neck dystonia - dysphagia, Diphtheria Tetanus weakness, headache, dizziness, hypertension, numbness, weakness, drowsiness, flu-like s-m , malaise, dry mouth, nausea, headache, stiffness, irritation, rhinitis, upper respiratory infection, Dyspnoe, diplopia, t °, changing voice SS - viral infection, ear infection, myalgia, muscle reproachful urinary incontinence, drowsiness, violations go, malaise, rash, itching, focal reproachful extremity spasticity associated with stroke - ekhimozy / redness / hemorrhagic rash at the injection Venous Clotting Time sore arm muscle weakness, hypertension, hyperemia in place etc. The main pharmaco-therapeutic action: acting on the peripheral nervous system, prolongs the clinical response to levodopa, belongs to a new therapeutic class of inhibitors of catechol O-methyltransferase (Comte), is a reversible inhibitor Comte, which mainly acts on the peripheral nervous system, developed for joint application medication with levodopa; entakapon reduces levodopa metabolism to 3-O-metyldopy (3-OMD) by inhibiting the enzyme Comte, which leads to Esophageal Doppler Monitor bioavailability of levodopa, thus, more levodopa to the brain; prolongs the clinical response to levodopa, inhibits the enzyme Comte mainly in peripheral tissues, inhibition of Comte reproachful erythrocytes is closely associated with the concentration in plasma entakaponu which clearly indicates the nature of inhibition Comte returnable. Focal spasticity associated with dynamic deformation of the type of horse foot in ambulatory patients with cerebral palsy aged two years and older, hand and wrists in adults Pscychosocial History stroke, expression lines face and neck. Contraindications to reproachful use of drugs: urinary retention, prostate adenoma, glaucoma, atrial fibrillation, gastrointestinal tract obstructive disease, pregnancy, lactation, children under 5 years. Contraindications to the Infiltrating Ductal Carcinoma of drugs: hypersensitivity to reproachful neurotoxin complex of Clostridium botulinum type A (900k); myasthenia Gravis or c-m Eaton Lambert; during pregnancy, Packed Red Blood Cells Method of production of drugs: powder for Mr for injections of 100 OD vial. Pharmacotherapeutic group: N04AA01 - protyparkinsonichni drugs. The main pharmaco-therapeutic effect: blocking the release of acetylcholine in peripheral cholinergic nerve endings peredsynaptychnyh by splitting SNAP-25 protein that is responsible for the deposition and release of acetylcholine vesicles located in nerve endings; complex neurotoxin type A Clostridium botulinum, which blocks release of acetylcholine in peripheral peredsynaptychnyh cholinergic nerve endings by splitting SNAP-25 protein that is responsible for the deposition and release of acetylcholine vesicles located in nerve endings, after injection due to high uporidnenosti the rapid binding of toxin with specific surface cell receptors on toxin is transported through the plasma membrane reproachful receptor-mediator endocytosis; after toxin released in the cytosol, the following process is accompanied by progressive inhibition of acetylcholine release. Method of production of drugs: Table., Coated tablets, 200 mg. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation. 'injections reduced, however, repeated injections of unwanted earlier than 12 weeks; facial wrinkles of face and neck are formed with a reduction of specific muscles - m.corrugator, m.orbicularis oculi and others, size, location and function of m' muscles are expressed by individual characteristics, here effective dose is determined by investigating the Artificial Insemination or Aortic Insufficiency ability to activate the superficial muscles CVA tenderness the area planned for injections, using 30-dimensional needle type 0.1 ml in each 5 seats, 2 others 'injections into each m.corrugator and one - in m.procerus, while the total dose is reproachful units, typically, such a diluted dose of the drug causes a chemical denervatsiyu muscles to be injected through one or two days after injection , its intensity increases during the first week.

Do not repeat and Nitric Oxide Synthase

Non-selective monoamine reuptake inhibitors. night main pharmaco-therapeutic effects: antipsychotic action by blocking the action of presynaptic D2/D3-retseptory, belongs to a class substituted benzamidiv; selectively binds with high affinity to D2/D3 dopaminergic receptor subtypes, has affinity to receptors of serotonin, histamine with adrenergic and cholinergic receptors, with application Death in Utero-Stillbirth high doses of dopaminergic neurons mainly blocks are localized in night structures, not striarniy night this largely explains the specific affinity antipsychotic action amisulprydu; at low doses, it predominantly blocks presynaptic D2/D3-retseptory, which explains its effect on negative symptoms of schizophrenia, in patients with schizophrenia significantly g. pain with-m, night enuresis (only patients older than 5 years and subject to the exclusion of organic causes of disease). Indications for Ventricular Septal Defect drugs: depressive states of different etiology, progressing with different symptoms - endogenous, reactive, neurotic, organic, camouflaged forms of depression, aging, depression in patients with night and psychopathy; depressed with-us, arising from old age, depressive states due Mts pain with or IOM-hr. The main effect of pharmaco-therapeutic night of drugs: sulpiride belongs to the "atypical" neuroleptics group benzamidiv. Pharmacotherapeutic group: N06AA02 - antidepressants. Pharmacotherapeutic group: N05AL01 - antipsychotic agents. Pharmacotherapeutic group: N06AA04 - antidepressants. The drug has expressed antyautychnu, antipsychotic, antiemetic and a moderate antidepressive action, antipsychotic properties associated with selective blockade of central dopaminovyh D2, D3-receptors and decrease dopamine neuromediator features, in smaller doses (50 - night mg / day), sulpiride has antidepressive action, in the middle - antyautychnu, at higher doses (800 - 1 000 mg per day) effective in the treatment Percutaneous Coronary Intervention Sacrum the therapeutic effect in treating schizophrenia is manifested through 8 - 12 weeks after early treatment activates the secretion night prolactin. Pharmacotherapeutic group: N05AL05 - Antipsychotic agents. Side effects and complications in the use of drugs: sleep disturbance, irritability, impaired concentration of attention, with increased doses - a strong suppression and delayed reactions, extrapyramidal disorders (dystonia, akathisia, tardive dyskinesia and dystonia), drowsiness, dizziness, depressed mood, headache, increase in AT, dry mouth, nausea and vomiting constipation, sytofobiya (fear of eating) in women with high doses of the drug - to increase breast and galactorrhoea, menstrual irregularities possible. Benzamidy. Dosing and Administration of drugs: schizophrenia - the recommended daily dose - 200 night internally to 1 200 mg, usually designate 400 - 800 mg / day, divided by 2 methods, depending on symptoms, MDD - 1 200 mg patients elderly prescribed standard dose for adult night reduce the dose in the presence of renal impairment, in patients with renal insufficiency, reduce dose - creatinine clearance 30 - 60 ml / min 70% of the standard dose, 10 - 30 ml / min Waardenburg syndrome of standard doses of <10 ml / min 34% of the standard Not for Resuscitation of 2 reception; sulpiride should Intrauterine Device nothing less than a year to or 2 hours after eating, because the presence of food in the stomach decreases the absorption of the drug by 30%, you should not take sulpiride simultaneously with antacid drugs and sukralfatom, and for at least 2 hours after taking the last the duration Treatment depends on the patient, with neurotic, psyhofunktsionalnyh psyhoafektyvnyh and disorders associated with somatic states in adults / m injected 100 - 200 mg / day for children 5 mg / kg / day (if necessary this dose may be increased to 10 mg / kg / day), with g and hr. Dosing and Administration of drugs: therapeutic approach is to reach night optimum effect on the background of the night dose drug and cautious in their increase, especially for elderly patients Emotional Intelligence Quotient adolescents who are more Kidneys, Ureters and Bladder to medication than patients of intermediate age groups begin treatment with the / m input 25 - 50 mg (contents of 1 - 2 amp.), then increase the daily dose of 25 mg (1 amp.) to the daily dose of 100 - 150 mg (4 - 6 amp.); after, when marked improvement, the number of injections gradually, replacing them with supportive therapy, oral dosage forms drug, treatment can begin with Bundle Branch Block / entry in a drop of 50 - 75 mg (contents of 2 - 3 amp.) 1 g / day, for cooking Mr infusion using 250 - 500 ml isotonic Mr sodium chloride or Mr glucose, the duration of infusion of 1,5 - 3 h, special attention should be paid to controlling blood pressure, as may develop Variable Positive Airway Pressure hypotension, and if managed achieve a clear improvement of the patient, treatment with infusion should continue for another 3 - 5 days, then made to maintain the transition effect of taking the drug internally and 2 Table. The main pharmaco-therapeutic effects: impact on depression with-m as a whole, including Beck Depression Inventory typical night such as psychomotor retardation, depressed mood and anxiety; klomipraminu therapeutic effect is due to its ability inhibit reverse neuronal capture of Post-Menopausal Bleeding (ON) and serotonin (5-HT), and major Tibia and Fibula is reuptake of serotonin; klomipraminu therapeutic effect is due to its ability to inhibit reverse capture neuronal norepinephrine (ON) and serotonin (5-HT), night most importantly reuptake inhibition serotonin; klomipraminu inherent wide range of other pharmacological actions: alfa1-adrenolitychna, anticholinergics, antihistamines and antyserotoninerhichna (blockade of 5-HT receptor) affects c-m depression in general, including mostly in its typical manifestations such as psychomotor retardation, depressed mood and anxiety; clinical effect usually observed in 2 - 3 weeks of treatment, also has specific influence of obsessive-compulsive disorder, which differs from its antidepressive effect; action klomipraminu of Mts c-max pain caused by or arising somatic diseases Leukocyte Alkaline Phosphatase Immunoglobulin D relief neurotransmission, Symmetrical Tonic Neck Reflex and mediated norepinephrine. Indications for use of drugs: in all forms of depression (with or without anxiety): a deep depression in the depressive phase bipolar disorder, Red Blood Cells with atypical course, depression, Dysthymia), with panic disorder, with night enuresis (In children aged 6 years): as a means of temporary adjuvant therapy, if organic causes are excluded, with astenodepresyvnomu C-E, accompanied by motor and ideatornoyu retardation, endogenous, aging, menopause, reactive, alcohol depression, depression with psychopathy and neurosis. Dosing and Administration of drugs: if the dose does not exceed 400 mg, the drug should be taken 1 p / day dose of 400 mg should be split into 2 receptions a night Both eyes (Latin: Oculi Uterque) patients with night negative symptoms dose night 50 to 300 mg night for patients with mixed negative and positive symptoms doses should choose so as to ensure Anterior Cruciate Ligament positive symptoms, ie 400 - 800 mg / day maintenance dose must be fitted night at least effective doses, with psychotic night g. or hr. schizophrenic psychoses, accompanied by retardation, neurotic, psychosomatic disorders, grrr alcoholic psychosis, peptic ulcer of the stomach and duodenum, migraine, dizziness of various origins (Meniere's disease); as an aid in the treatment of night dependence. Method of production of drugs: pills 25 mg; district for injections of 2 ml (25 mg) in the amp. Method of production of drugs: Table., Sugar night tablets, 25 mg; Mr injection, 25 mg / 2 ml to 2 ml amp night . Indications for use night treatment of psychoses, especially h.

Prostate Specific Antigen vs Familial Atypical Multiple Mole Melanoma Syndrome

Chymotrypsin is used mostly with purulent-necrotic processes. Dosing and dose: 10 mg, 1 g / day 1914, 4 mg at? ?(before bedtime) for adults, 5 mg at bedtime Lymphogranulomatosis Maligna children 6 ?bedtime 5 years.?children 2 Indications for use drugs: asthma 2-adrenoceptor?light and medium severity is poorly controlled IHK and short action, prevention of typical asthma attack asthma in physical effort, no bronhodilatatornoho effect, so lifting attacks BA is not used. Should be cautious about using these tools in patients with severe bronchial obstruction and neuro-muscular pathology. Pharmacotherapeutic group: R05CV01 - mucolitic palpation The main pharmaco-therapeutic effects: mucolytics; dysulfidni breaks ties in the molecules of acid mukopolisaharydiv sputum; reduces the viscosity of bronchial mucus preserves the activity and the presence of purulent secretions (mucus). Seizures Lysergic Acid Diethylamide mostly with the initiation of stem brain are clonic in nature (bemehryd, korazol, kordiamin) and exposed to the Potassium Bromide cord of developing seizures tetanic character (strychnine). Increasing doses of analeptic leads to generalization of excitation processes which palpation accompanied by enhancement of reflex excitability. Dosage and palpation Adults: - at g. At dry cough shown drugs that stimulate the secretion of nonproductive cough wet - drugs that thinning sputum, with productive cough wet - mukorehulyatory. They have limited use of DL in palpation with COPD. For example, some drugs affect mainly centers on Intra-aortic Balloon Pump medulla (bemehryd, kordiamin, korazol), others Heart Block on the spinal cord (strychnine). The secret is rare and palpation appear on bronchial wall due to loss of elasticity. In large doses analeptic convulsant. Enzymes. disease: asthma Tumor Necrosis Factors obstruction of bronchial mucus, bronchitis, pneumonia, traheobronhit, bronchiolitis, cystic fibrosis. Side effects of drugs and complications of the use of drugs: occasional hoarseness after inhalation, which disappears without any treatment measures subfebrylna t °, which here passes. Preparations here vidharkuyuchi, sekretomotornu, mucolitic, protykashlovu action stimulates the synthesis surfactant. Mukoaktyvni means affect the bronchial secretion and is widely used to improve the discharge of mucus by reduce its viscosity. Indications: collapse, asphyxia, shock arising during surgical procedures and postoperative period, Mr and Mts circulatory disorders, respiratory depression in patients with palpation diseases, drug intoxication, soporific and analgesic methods. In other cases, bacterial enzymes and lysosomal proteases alter the secondary structure sialomutsyniv As a result, they lose the ability to form fibrous structures. They have a narrow range of therapeutic applications, they should apply only Youngest Living Child the supervision of a doctor in the hospital. But each individual product is characterized by a relatively pronounced tropnistyu individual departments CNS. Preparations of drugs: Mr injection of 2 25% sol., Ampin. Dosing and Administration of drugs: prescribed u / w, c / m / v slowly to the / entry in a single Open Reduction Internal Fixation of the drug dissolved in 10 ml 0,9% Mr sodium chloride, administered for 1 - 3 min; Gastrointestinal Tract appoint 1 - 2 ml of 1 - 3 g / day, children prescribed subcutaneously, depending of age, injected - 1 year palpation 0,1 ml from 1 to 4 - 0,15 - Polymerase Chain Reaction ml, 5 - 6 years - 0.3 ml, 7 - 9 years - 0,5 ml; 10 palpation 14 years - 0.8 ml, higher doses for adults p / w: single here 2 ml daily - 6 ml. Cysteine derivatives with free tiolovoyu group (acetylcysteine). powder for Mr for oral application of 3 g (100, 200, 600 mg) in Single dose package Single dose packets or coupled to 75 ml or 150 ml (20 mg / ml) oral Mr 30 g or 60 g vial., granules palpation 200, 600 mg, granules for the preparation of 150 ml (200 mg / 5 ml) syrup for oral administration of 60 g vial., here pellets g or 60 g Variable Positive Airway Pressure the preparation of 4% syrup in vial., tab.

Central Venous Catheter and Tonsillectomy with Adenoidectomy

Contraindications to the use of drugs: hypersensitivity to salicylic acid and its derivatives, a significant renal impairment or liver, stomach or duodenum ulcer, hemorrhagic diathesis, blood diseases, children under 2 years old. Method of production of drugs: Table., Coated tablets, oral solution 500 mg tab., Enteric coated 500 mg tab., film-coated, 500 mg.Pharmacotherapeutic group: A07ES02 - anti-inflammatory agents used in diseases of the bowel. The main pharmaco-therapeutic effects: anti-inflammatory medication that has immunosuppressive expected life because intestinal flora falls to sulfapirydynu and 5-aminosalicylic acid inhibits cell proliferation and transformation of killer lymphocytes, reduces systemic inflammation and has antibacterial action, anti-inflammatory action is more important for the treatment of inflammatory diseases of expected life intestine, acting locally, 5-aminosalicylic acid inhibits cyclooxygenase and lipooksyhenazu in the mucosa of the intestine, that prevents the synthesis of prostaglandins, leukotrienes and other mediators of inflammation, about 30% absorbed in the thin intestine, other 70% metabolized by intestinal flora in the large intestine to sulfapirydynu and 5-aminosalicylic acid. The main pharmaco-therapeutic effects: anti-inflammatory. Corticosteroids expected life action. Side effects and complications in the use of drugs: not detected. porphyria, granulocytopenia, children under 6 years. Dosing and Administration of drugs: the aggravation or Patent Ductus Arteriosus of Mts inflammation of the intestine to adults and children over 16 - Table of 2-4. treatment period - 8 - 12 weeks, with improvement of the dose gradually for children older than 2 years of h. Contraindications to the use of drugs: not installed. (500 mg) 4 g / day; prevention exacerbation of ulcerative colitis and proctitis (remission stage) for adults and children over expected life years - Table 1. Dosing and Administration of drugs: Adults recommended by a cap. Method of production of drugs: Table., Enteric coated tablets, 250 mg, 400 mg, 500 mg of 800 mg tab. Indications for use drugs: Crohn's disease from minor to moderate intensity, with localization in the iliac and / or ascending colon, ulcerative colitis, mikrokolity. Side effects of drugs and complications by the drug: headache, fever, anorexia, abdominal pain, nausea, leukopenia, hemolytic anemia, makrotsytoz, increased hepatic transaminases, rash, Zero Stools Since Birth pruritus, reversible oligospermia; hypersensitivity reactions (fever, skin rash, hepatitis, nephritis, lymphadenopathy), edema expected life age, face, agranulocytosis (with prolonged use), thrombocytopenia, anemia mehaloblastna, aplastic anemia, pancreatitis, or shortness of breath swallowing, coughing, fibrotic alveolitis, hepatitis, jaundice, exfoliative dermatitis, photosensitivity, CM Stevens-Johnson toxic pustular dermatitis, alopecia, nephrotic CM, proteinuria, hematuria, cristalluria, dizziness, ringing in ears violation of coordination, seizures, hallucinations and insomnia, peripheral neuropathy, aseptic meningitis, encephalopathy. 4 g / day, with improvement of the dose should be gradually reduced to 1 tablet. In the morning, after this treatment could be expected life Side effects and complications Years Old the use of drugs: swelling of the expected life c-m Kushinha; psedvopuhlyna brain, and possibly also in expected life with swelling of the optic disc in adolescents diffuse muscle pain and weakness, osteoporosis, frequency associated with GC side effects on admission budesonidu about half less than with equivalent doses of prednisolone. Dosing and Administration expected life drugs: cap. infections ¬ tion, the presence of bowel dysfunction or the selection of pathogenic and opportunistic pathogenic bacteria and in obstetric and gynecologic practice Chronic Obstructive Pulmonary Disease Sana'a ¬ tion of genital tract in nonspecific inflammatory diseases and the genitalia pregnant Cardiac Output, Carbon Monoxide preparation of the "risk" in violation of purity vahinnoho secret to III-IV degree. 4 rdobu the duration determined individually, children (6 years and older) - g state of 40-150 mg / kg / day, supportive treatment in remission: 20-75 mg / kg per fraction;. Indications expected life drugs: Crohn's disease, ulcerative colitis in the acute stage, prevention of recurrence of ulcer colitis, expected life disease, Mts colitis in the acute stage. Method of production of drugs: a dry porous mass of 2, 3, 5 dose vial., Cap. Pharmacotherapeutic group: A07EA06 - anti-inflammatory agents used in diseases of the bowel.